🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will determine the immunogenicity of Spikogen in vaccine naïve i...
Status
Completed
Location
ARASMI
Start Date
2022-08-15
Trial ID
NCT05279456
Treatments Being Tested
This is a phase III, randomized, two-armed, double-blind, placebo-controlle...
Status
Completed
Location
Espinas Palace Hotel
Start Date
2021-08-07
Trial ID
NCT05005559
Treatments Being Tested
This is a Phase 1, multicenter, randomized, double-blind, placebo-controlle...
Status
Recruiting
Location
Comprehensive Center for Brain Health
Start Date
2026-06-23
Trial ID
NCT07158905
Treatments Being Tested
The purpose of the study is to assess the effectiveness of Spikogen vaccine...
Status
Completed
Location
ARASMI
Start Date
2022-09-07
Trial ID
NCT05542862
Treatments Being Tested
This is a study to test a new vaccine (Covax-19) against COVID-19. COVID-19...
Status
Completed
Location
PARC,
Start Date
2020-06-30
Trial ID
NCT04453852
Treatments Being Tested
The purpose of this study is to assess the potential use of delta-inulin as...
Status
Unknown
Location
Royal Adelaide Hospital
Start Date
2016-10
Trial ID
NCT03066986
Treatments Being Tested
This is a phase II, randomized, two-armed, double-blind, placebo-controlled...
Status
Completed
Location
Espinas Palace Hotel
Start Date
2021-05-30
Trial ID
NCT04944368
Treatments Being Tested
This is an open-label, single-arm clinical trial designed to evaluate the i...
Status
Completed
Location
Shaheed Labbafinezhad Hospital
Start Date
2022-02-04
Trial ID
NCT05285384
Treatments Being Tested
This was a non-randomized, three-armed, open-label, parallel-group, non-inf...
Status
Completed
Location
Orchid Life Department, Orchid Pharmed Company
Start Date
2022-02-23
Trial ID
NCT05231590
The purpose of the current study is to assess the effectiveness of protein-...
Status
Recruiting
Location
ARASMI
Start Date
2024-05-01
Trial ID
NCT06355232
Treatments Being Tested